Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Gabriel Zada

Neurological Surgery Los Angeles, CA Medical Doctor

NPI 1871768556 CMS profile 900500

1520 San Pablo St Ste 3800, Los Angeles, CA 90033

Open in the dashboard

General payments

$194,059

150 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$3,589,985

11 holdings reported · through program year 2025

Research they led as principal investigator

$55,071 paid to institutions, not to them · program years 2021–2022

Through program year 2025, Gabriel Zada of Los Angeles, CA is reported in the CMS Open Payments database as having received $194,059 across 150 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $55,071 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $3,589,985 across 11 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 94th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

13 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $6,119 2
2024 General $69 2
2023 General $56,631 44
2022 General $39,610 24
2021 General $15,057 9
2020 General $5,499 6
2019 General $71,073 63
2025 Ownership $120,250 1
2024 Ownership $823,871 2
2023 Ownership $823,871 2
2022 Ownership $698,872 2
2021 Ownership $561,560 2
2020 Ownership $561,560 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Gabriel Zada
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Gabriel Zada were reported at $6,119. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Gabriel Zada Neurological Surgery median Middle half National median
2019 $71,073 $582 $138–$3,006 $163
2020 $5,499 $294 $76–$2,174 $114
2021 $15,057 $387 $105–$2,432 $132
2022 $39,610 $542 $139–$2,989 $149
2023 $56,631 $534 $145–$2,697 $160
2024 $69 $574 $155–$3,046 $164
2025 $6,119 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $171,540 124 payments
  2. NICO Corporation $7,579 5 payments
  3. Medtronic, Inc. $4,550 1 payment
  4. Integra LifeSciences Corporation $3,943 4 payments
  5. Elekta, Inc. $2,003 5 payments
  6. KARL STORZ Endoscopy-America $2,000 1 payment
  7. Osteomed LLC $1,679 4 payments
  8. Medtronic USA, Inc. $230 1 payment
  9. Viseon, Inc. $187 2 payments
  10. Monteris Medical Corporation $119 1 payment
  11. Other $229 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $153,261 31 payments
  2. Travel and Lodging $22,082 52 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $6,550 2 payments
  4. Honoraria $5,500 2 payments
  5. Food and Beverage $3,637 61 payments
  6. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $3,000 1 payment
  7. Education $28 1 payment
Products named General payments · program years 2019–2025
  1. CORE $87,240 40 payments
  2. NSE - SONOPET $27,079 7 payments
  3. UNIVERSAL NEURO $24,304 8 payments
  4. ADHERUS AUTOSPRAY DURAL SEALANT $24,302 11 payments
  5. SONOPET IQ $20,837 4 payments
  6. NSE - HIGH SPEED DRILLS $19,315 21 payments
  7. UNIVERSAL MANDIBLE $10,850 1 payment
  8. DIRECT INJECT $7,700 1 payment
  9. NICO FLUID SYSTEM $6,000 1 payment
  10. NICO AUTOMATED PRESERVATION SYSTEM $6,000 1 payment
  11. Other $44,063 74 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 28 billing codes

Paid by Medicare

$62,106

Medicare's payments for the services billed

Medicare patients

152

Average age 71

Services billed

227

88 women, 64 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 55%
Diabetes 38%
Ischemic heart disease 33%
Depression 30%
Osteoporosis 21%
Chronic kidney disease 17%
Atrial fibrillation 14%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

150 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record